/Investor DB

ICV — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

NeuroDexneurodex.coinSeed · Feb 2020 · $500K

NeuroDex develops blood-based biomarkers and diagnostic assays for neurological diseases, including rare genetic disorders, Parkinson's disease, Alzheimer's disease, and ALS.

BiotechDigital HealthMedical DevicesArlington, US

Erez Eitan(Executive Officer, Director)inRaphael Nir(Director)Oded Biran(Executive Officer, Director)

Co-investorsFormation Venture Engineering

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.